loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 1914022 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 POTASSIUM CITRATE (1)

filter

01 MISSION PHARMACAL COMPANY (1)

filter

01 TABLET (EXTENDED-RELEASE) (1)

filter

01 540MG (1)

filter

01 Canada (1)

TABLET (EXTENDED-RELEA...
540MG
UROCIT-K
Canada
1914022
100
Prescription

Looking for CTD TGA MCC DOSSIER APPLICATION 1914022

Looking for CTD TGA MCC DOSSIER APPLICATION 1914022 1

19

Mission | CDMO, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

One of their notable products is POTASSIUM CITRATE, with a corresponding application number 1914022 and regulatory information .

proudly manufactured in the

Mission | CDMO's UROCIT-K TABLET (EXTENDED-RELEASE), medication with 540MG of POTASSIUM CITRATE.

Post Enquiry
POST ENQUIRY